These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 17604870)

  • 21. Fabrication of covered porous PLGA microspheres using hydrogen peroxide for controlled drug delivery and regenerative medicine.
    Bae SE; Son JS; Park K; Han DK
    J Control Release; 2009 Jan; 133(1):37-43. PubMed ID: 18838089
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives.
    Mundargi RC; Babu VR; Rangaswamy V; Patel P; Aminabhavi TM
    J Control Release; 2008 Feb; 125(3):193-209. PubMed ID: 18083265
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Versatility of biodegradable poly(D,L-lactic-co-glycolic acid) microspheres for plasmid DNA delivery.
    Díez S; Tros de Ilarduya C
    Eur J Pharm Biopharm; 2006 Jun; 63(2):188-97. PubMed ID: 16697172
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Indocyanine green-loaded biodegradable nanoparticles: preparation, physicochemical characterization and in vitro release.
    Saxena V; Sadoqi M; Shao J
    Int J Pharm; 2004 Jul; 278(2):293-301. PubMed ID: 15196634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preparation of rifampicin-loaded PLGA microspheres for lung delivery as aerosol by premix membrane homogenization.
    Doan TV; Olivier JC
    Int J Pharm; 2009 Dec; 382(1-2):61-6. PubMed ID: 19682562
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Formulation and in vitro characterization of inhalable rifampicin-loaded PLGA microspheres for sustained lung delivery.
    Doan TV; Couet W; Olivier JC
    Int J Pharm; 2011 Jul; 414(1-2):112-7. PubMed ID: 21596123
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of formulation composition and process on the characteristics and in vitro release from PLGA-based sustained release injectables.
    Meeus J; Scurr DJ; Appeltans B; Amssoms K; Annaert P; Davies MC; Roberts CJ; Van den Mooter G
    Eur J Pharm Biopharm; 2015 Feb; 90():22-9. PubMed ID: 25448071
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Engineered PLGA nano- and micro-carriers for pulmonary delivery: challenges and promises.
    Ungaro F; d'Angelo I; Miro A; La Rotonda MI; Quaglia F
    J Pharm Pharmacol; 2012 Sep; 64(9):1217-35. PubMed ID: 22881435
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microencapsulation of protein drugs for drug delivery: strategy, preparation, and applications.
    Ma G
    J Control Release; 2014 Nov; 193():324-40. PubMed ID: 25218676
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel biodegradable system based on gelatin nanoparticles and poly(lactic-co-glycolic acid) microspheres for protein and peptide drug delivery.
    Li JK; Wang N; Wu XS
    J Pharm Sci; 1997 Aug; 86(8):891-5. PubMed ID: 9269865
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanical properties and dual drug delivery application of poly(lactic-co-glycolic acid) scaffolds fabricated with a poly(β-amino ester) porogen.
    Clark A; Milbrandt TA; Hilt JZ; Puleo DA
    Acta Biomater; 2014 May; 10(5):2125-32. PubMed ID: 24424269
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preparation of large porous biodegradable microspheres by using a simple double-emulsion method for capreomycin sulfate pulmonary delivery.
    Giovagnoli S; Blasi P; Schoubben A; Rossi C; Ricci M
    Int J Pharm; 2007 Mar; 333(1-2):103-11. PubMed ID: 17079101
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PLGA microparticles encapsulating prostaglandin E1-hydroxypropyl-β-cyclodextrin (PGE1-HPβCD) complex for the treatment of pulmonary arterial hypertension (PAH).
    Gupta V; Davis M; Hope-Weeks LJ; Ahsan F
    Pharm Res; 2011 Jul; 28(7):1733-49. PubMed ID: 21626061
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of zinc in formulation of PLGA/PLA nanoparticles encapsulating betamethasone phosphate and its release profile.
    Ishihara T; Izumo N; Higaki M; Shimada E; Hagi T; Mine L; Ogawa Y; Mizushima Y
    J Control Release; 2005 Jun; 105(1-2):68-76. PubMed ID: 15955367
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of freeze-drying with different cryoprotectants and gamma-irradiation sterilization on the characteristics of ciprofloxacin HCl-loaded poly(D,L-lactide-glycolide) nanoparticles.
    Bozdag S; Dillen K; Vandervoort J; Ludwig A
    J Pharm Pharmacol; 2005 Jun; 57(6):699-707. PubMed ID: 15969924
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preparation and evaluation of poly(lactic-co-glycolic acid) microparticles as a carrier for pulmonary delivery of recombinant human interleukin-2: II. In vitro studies on aerodynamic properties of dry powder inhaler formulations.
    Devrim B; Bozkır A; Canefe K
    Drug Dev Ind Pharm; 2011 Nov; 37(11):1376-86. PubMed ID: 21548727
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Silicon microfluidic flow focusing devices for the production of size-controlled PLGA based drug loaded microparticles.
    Keohane K; Brennan D; Galvin P; Griffin BT
    Int J Pharm; 2014 Jun; 467(1-2):60-9. PubMed ID: 24680950
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimization of ciprofloxacin complex loaded PLGA nanoparticles for pulmonary treatment of cystic fibrosis infections: Design of experiments approach.
    Günday Türeli N; Türeli AE; Schneider M
    Int J Pharm; 2016 Dec; 515(1-2):343-351. PubMed ID: 27744035
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors affecting drug encapsulation and stability of lipid-polymer hybrid nanoparticles.
    Cheow WS; Hadinoto K
    Colloids Surf B Biointerfaces; 2011 Jul; 85(2):214-20. PubMed ID: 21439797
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of lung surfactants on rifampicin release rate from monodisperse rifampicin-loaded PLGA microspheres.
    Tomoda K; Makino K
    Colloids Surf B Biointerfaces; 2007 Mar; 55(1):115-24. PubMed ID: 17197161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.